Excelra

Excelra Excelra's data and analytics solutions empower innovation in life sciences across the value chain from discovery to market.

The Excelra Edge comes from a seamless amalgamation of proprietary curated data assets, deep domain expertise and data science. The company's multifaceted teams harmonize and analyze large volumes of disparate unstructured data using cutting-edge technologies. We galvanize data-driven decisions to unlock operational efficiencies to accelerate drug discovery and development. Over the past 18 years,

Excelra has been the preferred data and analytics partner to over 90 global clients including 15 of the top 20 large Pharma companies.

We’re excited to be part of the Festival of Genomics, Biodata & AI 2026 as an Agenda Partner & Exhibitor.Join us at Boot...
18/05/2026

We’re excited to be part of the Festival of Genomics, Biodata & AI 2026 as an Agenda Partner & Exhibitor.
Join us at Booth #11 to discover how Excelra is helping life sciences organizations accelerate AI-driven drug discovery through bioinformatics, scientific informatics, AI-ready data, and curated knowledgebases like GOSTAR™.

From multi-omics analysis to connected R&D data ecosystems, we’re enabling faster insights and smarter research decisions across the drug discovery journey.

📍 MCEC, Boston
📅 June 3–4, 2026

We’re exhibiting at the Festival of Genomics 2026Meet us at Booth  #11 to discover how we’re helping life sciences organ...
14/05/2026

We’re exhibiting at the Festival of Genomics 2026
Meet us at Booth #11 to discover how we’re helping life sciences organizations unlock the full potential of genomics, biodata, and AI-driven research.

From multi-omics bioinformatics and scientific informatics to AI-ready data and curated knowledgebases like GOSTAR™, we enable faster insights, smarter decisions, and more connected R&D workflows across drug discovery and translational research.

📅 June 3-4, 2026
📍 MCEC, Boston

See you there!

Meet our experts at Bio-IT World Conference & Expo 2026!Schedule a meeting: https://na2.hubs.ly/H05qXmc0 Join us at Boot...
12/05/2026

Meet our experts at Bio-IT World Conference & Expo 2026!
Schedule a meeting: https://na2.hubs.ly/H05qXmc0

Join us at Booth #717 at the Boston, MA from May 19–21, 2026. Connect with our team to discuss AI-driven drug discovery, bioinformatics, and scientific informatics solutions accelerating life sciences innovation.

Discover how Excelra helps organizations turn complex biomedical data into actionable insights for faster R&D. Let’s connect at Bio-IT World 2026.

11/05/2026

Drug discovery teams don’t struggle with a lack of genetic data.
They struggle with too much of it, spread across GWAS studies, PheWAS datasets, locus reports, and siloed research systems that rarely connect seamlessly. https://na2.hubs.ly/H05mwqJ0

Excelra solved this by building a Target Assessment Platform that unified genetic evidence, automated locus-level reporting, and enabled rapid target prioritisation through intelligent annotation workflows.

The result? Faster shortlisting, stronger genetic validation, and a scalable foundation for evidence-driven drug discovery.

Heading to Bio-IT World Conference & Expo 2026 in Boston?Join us for an insightful session by Jannick Bendtsen, Vice Pre...
08/05/2026

Heading to Bio-IT World Conference & Expo 2026 in Boston?
Join us for an insightful session by Jannick Bendtsen, Vice President, Bioinformatics and Data Science on “Transforming Precision Medicine: AI-Driven Biomarker Discovery and Patient Stratification in Data-Constrained Environments".

Wednesday, May 20, 2026 | 4:00 PM

This session will explore how AI-driven approaches are helping accelerate precision medicine by enabling smarter biomarker discovery and improved patient stratification, even when high-quality data is limited.

If you're working at the intersection of AI, bioinformatics, and precision medicine, this is a session you won’t want to miss.

What if the next breakthrough in precision oncology was hidden across fragmented molecular and clinical data, waiting to...
07/05/2026

What if the next breakthrough in precision oncology was hidden across fragmented molecular and clinical data, waiting to be connected?

Excelra developed an LLM-powered multimodal oncology data analysis platform that unified genomics, ctDNA, methylation profiles, EHRs, and claims data into a single, insight-driven ecosystem. Read the full case study: https://na2.hubs.ly/H05lnJF0

By combining advanced AI, contrastive learning, explainable analytics, and knowledge graphs, the platform enabled:
- 2–3× faster biomarker discovery
- 30–50% improvement in research efficiency
- Real-time analytics and hypothesis generation

The result? A scalable, future-ready foundation for GenAI-enabled precision oncology research.

  | The next breakthrough molecule could already be hidden in millions of sequencing reads, just waiting to be uncovered...
05/05/2026

| The next breakthrough molecule could already be hidden in millions of sequencing reads, just waiting to be uncovered.

For teams working with DNA-encoded libraries, that’s not a hypothetical. It’s the reality they deal with every day: https://na2.hubs.ly/H05hqcH0

Excelra enabled exactly that. By combining advanced bioinformatics, statistical modeling, and a scalable Nextflow-based pipeline, we transformed noisy DEL data into a reliable framework for hit identification. True signals emerged. False positives were reduced.

Read the full case study to see how true signals emerge from noisy DEL data

We’re exhibiting at the Bio-IT World Conference & Expo 2026.Meet us at Booth  #717 to explore how Excelra is enabling da...
30/04/2026

We’re exhibiting at the Bio-IT World Conference & Expo 2026.
Meet us at Booth #717 to explore how Excelra is enabling data-driven innovation across life sciences and healthcare.

From integrating complex biomedical data to building scalable informatics solutions, we help organizations accelerate research, enhance collaboration, and drive smarter decision-making.

📅 May 19–21, 2026
📍 Boston, MA

29/04/2026

Turning complex immune data into actionable discoveries
Behind every immunology breakthrough lies complex data. This World Immunology Day, Excelra supports transforming fragmented immune data into meaningful insights.

From immune profiling to multi-omics, scientists handle vast data across disconnected systems. The challenge is integrating it, accelerating analysis, and enabling faster decisions.

With AI-driven analysis and scalable solutions, Excelra helps researchers connect data, reduce complexity, and accelerate discovery.

Novo Nordisk’s Phase 3 success with etavopivat marks a major step forward for oral sickle cell therapy. But delivering c...
28/04/2026

Novo Nordisk’s Phase 3 success with etavopivat marks a major step forward for oral sickle cell therapy.

But delivering clinical success today requires more than hitting endpoints.
It demands the ability to connect clinical outcomes with underlying biological signals across complex datasets.

As trials evolve toward multi-endpoint validation, fragmented data can quickly become the bottleneck, slowing analysis, interpretation, and decision-making.

Explore how this shift is reshaping clinical research and why AI-ready, connected data is becoming critical for faster R&D.

Address

7th Floor Wing B
Uppal
500039

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm

Telephone

+91 40 6707 3333

Alerts

Be the first to know and let us send you an email when Excelra posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share